| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
thrombospondin 2 | 0.526 | 0.769 | 0.56 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
thrombospondin 1 | 0.407 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
solute carrier family 8 member B1 | 0.861 | 0.077 | 2.0E-16 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
solute carrier family 24 member 1 | 0.716 | 0.154 | 9.2E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
sequestosome 1 | 0.428 | 0.885 | 8.6E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
RELB proto-oncogene, NF-kB subunit | 0.597 | 0.731 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1991 | 2011 | ||||||||
|
nuclear factor kappa B subunit 2 | 0.509 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
NFKB inhibitor alpha | 0.487 | 0.885 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
microtubule associated protein 1 light chain 3 alpha | 0.610 | 0.654 | 2.8E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
metallothionein 2A | 0.553 | 0.808 | 1.2E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
metallothionein 1A | 0.537 | 0.808 | 4.5E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
matrix metallopeptidase 12 | 0.484 | 0.885 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2003 | 2012 | ||||||||
|
fms related receptor tyrosine kinase 1 | 0.419 | 0.846 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
dystroglycan 1 | 0.498 | 0.808 | 0.98 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
doublecortin | 0.511 | 0.769 | 0.30 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 |